Telehealth for Pain and Unhealthy Drinking Among PLWH

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBoston University

About this trial

This randomized controlled trial is a between-groups design to compare the Motivational and Cognitive Behavioral Management for Alcohol and Pain (MCBMAP) Intervention to a Brief Advice and Information Control condition.

Two-hundred and fifty participants who have HIV with moderate or greater chronic pain will be randomized for the trial. Recruitment will take place through digital media. A unique feature of this intervention trial is that most of the procedures will be conducted remotely which will minimize barriers of transportation and time for participants. Consent and baseline assessment will be completed remotely. Following baseline assessment, participants will complete two weeks of ecological momentary assessment (EMA) to assess alcohol use, chronic pain, physical function and mechanisms of behavior change for alcohol and pain management. Following the two-week phase, participants will be randomly assigned to either the intervention or control condition and meet the interventionist through videoconferencing. Participants will complete outcome assessment measures at 3- and 6-months post-baseline. Following the 3-month outcome assessment, participants will complete another two weeks of EMA.

Eligibility criteria

Qualifiers

Able to confirm HIV diagnosis, via visual evidence of antiretroviral (ART) medication bottle or medical record presented to study staff over Zoom.

>7 drinks for women / > 14 drinks for men per week.

OR ≥ 3 drinks for women / ≥4 drinks for men on one occasion in the past month.

Experiencing moderate or greater chronic pain (4 or greater on the numerical pain rating scale) for at least 3 months.

Disqualifiers

History of bipolar, schizoaffective disorder or schizophrenia per self report.

Unstable dose of psychoactive medication for pain or alcohol/substance use [i.e., if on medication, participant has not been on same dose for least 2 months]

History of withdrawal-related seizures or delirium tremens

Current non-pharmacological treatment for alcohol use disorder or chronic pain

Trial design

Treatments tested in this trial

  • MCBMAP
  • Brief Advice and Information

Treatment groups

385 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Boston University

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator